Is It Too Late To Consider McKesson (MCK) After Its Powerful Multi‑Year Rally?

Simply Wall St.02-27

If you are wondering whether McKesson is still reasonably priced after a strong run, this article explains what the current share price could imply about its underlying value. The stock last closed at...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614288581?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/288195-main-header/1756206015044","is_english":true,"pubTime":"2026-02-27 13:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614288581","market":"sg","top_or_hot":-1,"title":"Is It Too Late To Consider McKesson (MCK) After Its Powerful Multi‑Year Rally?","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether McKesson is still reasonably priced after a strong run, this article explains what the current share price could imply about its underlying value. The stock last closed at...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/is-it-too-late-to-consider-mckesson-mck-after-its-powerful-m\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Too Late To Consider McKesson (MCK) After Its Powerful Multi‑Year Rally?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Too Late To Consider McKesson (MCK) After Its Powerful Multi‑Year Rally?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-27 13:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/is-it-too-late-to-consider-mckesson-mck-after-its-powerful-m><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether McKesson is still reasonably priced after a strong run, this article explains what the current share price could imply about its underlying value. The stock last closed at...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/is-it-too-late-to-consider-mckesson-mck-after-its-powerful-m\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1585245621.USD","symbol_name":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/is-it-too-late-to-consider-mckesson-mck-after-its-powerful-m","article_id":"2614288581","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/288195-main-header/1756206015044"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-mck/mckesson/news/is-it-too-late-to-consider-mckesson-mck-after-its-powerful-m","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614288581","pubTimestamp":1772170305,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether McKesson is still reasonably priced after a strong run, this article explains what the current share price could imply about its underlying value.\nThe stock last closed at US$974.45, with reported returns of 4.0% over 7 days, 16.8% over 30 days, 18.3% year to date, 57.6% over 1 year and a very large gain over 5 years.\nRecent coverage of McKesson has focused on its role as a major healthcare distributor and on how investors may be reassessing its position in the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4585":"ETF&股票定投概念","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU1037948541.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (HKD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","BK4175":"保健护理产品经销商","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4588":"碎股","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU0861579265.USD":"联博低波幅策略股票基金A","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU0122379950.USD":"贝莱德世界健康科学A2","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","MCK":"麦克森药物批发","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC"},"translate_title":"在经历了多年强劲的反弹之后，现在考虑麦克森(MCK)是否为时已晚？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"MCK":1.5},"content_text":"If you are wondering whether McKesson is still reasonably priced after a strong run, this article explains what the current share price could imply about its underlying value. The stock last closed at US$974.45, with reported returns of 4.0% over 7 days, 16.8% over 30 days, 18.3% year to date, 57.6% over 1 year and a very large gain over 5 years. Recent coverage of McKesson has focused on its role as a major healthcare distributor and on how investors may be reassessing its position in the sector. This may help explain the strong share price performance over multiple timeframes. Ongoing interest in large, established healthcare names like McKesson often keeps valuation in focus for long term investors. Right now, McKesson has a valuation score of 4 out of 6, which means it screens as undervalued on four of six checks. Next we will look at how different valuation methods line up with that score and suggest a more complete way to think about value by the end of the article.  McKesson delivered 57.6% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: McKesson Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model takes the cash McKesson is expected to generate in the future and discounts those amounts back into today’s dollars to estimate what the business might be worth right now. For McKesson, the model uses a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $9.61b. Analyst and extrapolated projections suggest free cash flow between 2026 and 2035 generally sitting in the mid single digit billions each year, with an example estimate of $7.04b in 2030. Simply Wall St uses analyst inputs where available for the earlier years and then extends the projections further out to build a ten year cash flow path. After discounting these projected cash flows back to today, the DCF model arrives at an estimated intrinsic value of about $1,481.84 per share. Compared to the recent share price of $974.45, this implies a 34.2% discount, which indicates McKesson screens as undervalued on this model. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests McKesson is undervalued by 34.2%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks. MCK Discounted Cash Flow as at Feb 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for McKesson. Approach 2: McKesson Price vs Earnings For profitable companies like McKesson, the P/E ratio is a useful quick check because it directly links what you pay for each share to the earnings that business is currently generating. It is a simple way to see how the market is weighing those earnings today. What counts as a “normal” P/E depends on what investors expect for future growth and how much risk they see. Higher expected growth or lower perceived risk can support a higher P/E, while slower expected growth or higher risk usually lines up with a lower P/E. McKesson’s current P/E is 27.50x, compared with the wider Healthcare industry average of about 23.76x and a peer group average of 29.21x. Simply Wall St also calculates a “Fair Ratio” for McKesson of 35.55x. This Fair Ratio is a proprietary estimate of what the P/E could be, given factors like earnings growth, profit margins, industry, market cap and specific company risks. Because it folds these drivers into one figure, it can be more tailored than a basic comparison against industry or peers alone. With the Fair Ratio above the current P/E, this framework suggests the stock screens as undervalued on this metric. Result: UNDERVALUED NYSE:MCK P/E Ratio as at Feb 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies. Upgrade Your Decision Making: Choose your McKesson Narrative Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simple stories you create about McKesson that connect your view of its future revenue, earnings and margins to a specific fair value and then compare that to today’s share price. On Simply Wall St’s Community page, Narratives let you plug in assumptions, see how those feed into a forecast and a fair value, and then quickly assess whether McKesson looks attractive or stretched based on the gap between Fair Value and Price. Because Narratives are updated when new information like earnings or news arrives, you can see how your story needs to change and how that affects your fair value without rebuilding your whole view from scratch. For example, one McKesson Narrative today might lean closer to the higher analyst target of US$830 if you think expansion into specialty pharmaceuticals and efficiency gains could support stronger earnings. Another could sit nearer the US$640 low target if you are more focused on risks such as regulatory pressure, lower margin generics and consolidation across the healthcare supply chain. Do you think there's more to the story for McKesson? Head over to our Community to see what others are saying! NYSE:MCK 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614288581","isCrawlerRequest":true}